Mandate

VINGE ADVISES INDUSTRIFONDEN IN CONNECTION WITH INVESTMENT IN INRIVER

August 14, 2013

Vinge has advised Industrifonden which, together with Zobito, has invested a total of SEK 20 million in the Malmö-based software company, inRiver. inRiver’s software helps companies to manage product information in a simpler and more expeditious manner. The funds will be used to finance inRiver’s future international expansion in the US and other countries.

inRiver’s software allows customers to quickly and efficiently collect all product information by uploading texts in different languages, pictures of products and films in inRiver’s software – a process which is called Product Information Management (PIM). Products are placed on the market more quickly with PIM and the information can thereafter be quickly distributed and easily adapted for marketing and sales materials via various sales channels.

The company has expanded significantly in the last few years and has managed to achieve a leading position in the Nordic region in its field with customers such as Stadium, Lindex, Fazer, Gant, Haléns and Byggmax. iRiver has now commenced its international expansion by, among other things, establishing subsidiaries in the US and the Netherlands.

Vinge’s team consisted primarily of partner Johan Larsson and associates Karl Hahtovirta and Philip Watson.   

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024